As we all start to get into the festive spirit ahead of the holiday season, it’s a perfect time to reflect on achievements, and of course challenges across the past year. 2025 has been a big year for Purdie Pascoe, and in this short interview, Co-Founder Guy Pascoe provides insight into what has made this year so pivotal for the business.

Our dedicated division has evolved. While PMCF remains a core part of our offering, we’re now applying our expertise to broader areas, including other forms of Real World Data (RWD) collection and Post Market Performance Follow-Up (PMPF). In this conversation, Marcus and Ellie discuss the why behind the expansion of our services, the evolution of the team, and what it means for our clients at Purdie Pascoe.

In this piece, Marcus Torr, Head of Post Market Surveys, shares his reflections on the discussions shaping the regulatory landscape, the themes emerging across both events, and how continued collaboration can drive meaningful improvements in patient safety and lifecycle management.

By analysing data through a more granular lens, including disaggregation by gender, we can uncover meaningful insights, identify differential responses, and ultimately drive more equitable outcomes for all patient groups. Doing so also supports alignment with regulatory expectations around inclusive and evidence based post-market surveillance.

Attending this year’s RAPS Congress we were reminded of why we do what we do; at the heart of every conversation from regulatory reform to AI innovation there was one shared purpose: improving patients’ lives.

With over 50 of us now based across the UK, US, and Europe, this year’s meeting was a true celebration of our growth, our people, and our commitment to MedTech. Fittingly, our theme this year was bold and simple: MedTech, as it’s not just one of our sectors - it’s our sole focus.

While quantitative data can reveal what is happening, qualitative insights uncover the why; shedding light on patient experiences, clinician workflows, and unmet needs that numbers alone can't capture. By diving deep into real-world perspectives, MedTech companies can design more intuitive devices, craft compelling value propositions, and navigate complex regulatory and reimbursement landscapes with greater confidence.

Experts presenters from across the industry; Breda Kearny - Clinical Regulatory Lead, BSI, Diane M. Legere - Senior Clinical Auditor, DNV, Marcus Torr - Head of Post Market Surveys, Purdie Pascoe and Efsthathios Vassiliadis - CEO, Evnia.

As MedTech professionals know, the industry rarely sleeps, but let’s be honest: in August, it definitely takes a nap. With inboxes a little quieter and decision-makers (hopefully) stealing a few hours in the sun, it’s the perfect time for some lighter reflection. So, grab your iced coffee (or something stronger), and let’s talk Post Market Surveys, from the poolside.

Partnering with an external team that understands and supports every stage of the MedTech journey can be transformative. In this conversation, leading experts share how Purdie Pascoe’s integrated expertise in Primary Market Research and Post Market Surveys is the true golden ticket to a seamless, compliant, and impactful approach for success in your MedTech journey.

In a world where many agencies claim to serve MedTech, very few are true specialists. MedTech isn’t just one of our sectors - it’s our sole focus. That’s what sets us apart. We’re proudly returning to our roots and doubling down on what we do best; helping companies like yours make smarter, faster, and more confident decisions.